532 related articles for article (PubMed ID: 31094101)
61. The association of medical and demographic characteristics with sarcopenia and low muscle radiodensity in patients with nonmetastatic colorectal cancer.
Xiao J; Caan BJ; Cespedes Feliciano EM; Meyerhardt JA; Kroenke CH; Baracos VE; Weltzien E; Kwan ML; Alexeeff SE; Castillo AL; Prado CM
Am J Clin Nutr; 2019 Mar; 109(3):615-625. PubMed ID: 30850836
[TBL] [Abstract][Full Text] [Related]
62. Phase angle as a marker for muscle abnormalities and function in patients with colorectal cancer.
Souza NC; Avesani CM; Prado CM; Martucci RB; Rodrigues VD; de Pinho NB; Heymsfield SB; Gonzalez MC
Clin Nutr; 2021 Jul; 40(7):4799-4806. PubMed ID: 34271241
[TBL] [Abstract][Full Text] [Related]
63. Association of prognostic nutritional index with muscle loss and survival in patients with ovarian cancer treated with primary debulking surgery and chemotherapy.
Lee J; Weng CS; Chang CL; Hsu WH; Jan YT; Wu KP
Support Care Cancer; 2023 Apr; 31(5):267. PubMed ID: 37058264
[TBL] [Abstract][Full Text] [Related]
64. Obesity is Associated with Longer Survival Independent of Sarcopenia and Myosteatosis in Metastatic and/or Castrate-Resistant Prostate Cancer.
Xu MC; Huelster HL; Hatcher JB; Avulova S; Stocks BT; Glaser ZA; Moses KA; Silver HJ
J Urol; 2021 Mar; 205(3):800-805. PubMed ID: 33080148
[TBL] [Abstract][Full Text] [Related]
65. The relationship between the mode of presentation, CT-derived body composition, systemic inflammatory grade and survival in colon cancer.
Golder AM; Sin LKE; Alani F; Alasadi A; Dolan R; Mansouri D; Horgan PG; McMillan DC; Roxburgh CS
J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2863-2874. PubMed ID: 36218135
[TBL] [Abstract][Full Text] [Related]
66. Early postoperative decrease of skeletal muscle mass predicts recurrence and poor survival after surgical resection for perihilar cholangiocarcinoma.
Yasuta S; Sugimoto M; Kudo M; Kobayashi S; Takahashi S; Konishi M; Gotohda N
BMC Cancer; 2022 Dec; 22(1):1358. PubMed ID: 36578076
[TBL] [Abstract][Full Text] [Related]
67. Skeletal Muscle Attenuation (Sarcopenia) Predicts Reduced Overall Survival in Patients with Advanced Epithelial Ovarian Cancer Undergoing Primary Debulking Surgery.
Ataseven B; Luengo TG; du Bois A; Waltering KU; Traut A; Heitz F; Alesina PF; Prader S; Meier B; Schneider S; Koch JA; Walz M; Groeben HT; Nina P; Brunkhorst V; Heikaus S; Harter P
Ann Surg Oncol; 2018 Oct; 25(11):3372-3379. PubMed ID: 30069659
[TBL] [Abstract][Full Text] [Related]
68. Body Composition in Relation to Clinical Outcomes in Renal Cell Cancer: A Systematic Review and Meta-analysis.
Vrieling A; Kampman E; Knijnenburg NC; Mulders PF; Sedelaar JPM; Baracos VE; Kiemeney LA
Eur Urol Focus; 2018 Apr; 4(3):420-434. PubMed ID: 28753824
[TBL] [Abstract][Full Text] [Related]
69. Associations between muscle measures, survival, and toxicity in patients with limited stage small cell lung cancer.
Halvorsen TO; Valan CD; Slaaen M; Grønberg BH
J Cachexia Sarcopenia Muscle; 2020 Oct; 11(5):1283-1290. PubMed ID: 32725772
[TBL] [Abstract][Full Text] [Related]
70. The Impact of Muscle and Adipose Tissue on Long-term Survival in Patients With Stage I to III Colorectal Cancer.
Hopkins JJ; Reif RL; Bigam DL; Baracos VE; Eurich DT; Sawyer MB
Dis Colon Rectum; 2019 May; 62(5):549-560. PubMed ID: 30789442
[TBL] [Abstract][Full Text] [Related]
71. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.
Fujiwara N; Nakagawa H; Kudo Y; Tateishi R; Taguri M; Watadani T; Nakagomi R; Kondo M; Nakatsuka T; Minami T; Sato M; Uchino K; Enooku K; Kondo Y; Asaoka Y; Tanaka Y; Ohtomo K; Shiina S; Koike K
J Hepatol; 2015 Jul; 63(1):131-40. PubMed ID: 25724366
[TBL] [Abstract][Full Text] [Related]
72. Prognostic value of computed tomography associated body composition measurement changes in metastatic colorectal cancer patients.
Sevgilioglu ZE; Evrimler S; Iscan G; Kayikcioglu E; Sengul SS; Cetin B
Acta Radiol; 2023 Nov; 64(11):2849-2857. PubMed ID: 37661639
[TBL] [Abstract][Full Text] [Related]
73. Computed tomography-determined skeletal muscle density predicts 3-year mortality in initial-dialysis patients in China.
Sheng MJ; Cao JY; Hou SM; Li M; Wang Y; Fang Q; Miao AF; Yang M; Liu SS; Hu CH; Liu CL; Wang SY; Zheng J; Xiao JJ; Zhang XL; Liu H; Liu BC; Wang B
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2569-2578. PubMed ID: 37722854
[TBL] [Abstract][Full Text] [Related]
74. Changes of computed tomography-based body composition after adrenalectomy in patients with endogenous hypercortisolism.
Hong N; Lee J; Ku CR; Han K; Lee CR; Kang SW; Rhee Y
Clin Endocrinol (Oxf); 2019 Feb; 90(2):267-276. PubMed ID: 30428502
[TBL] [Abstract][Full Text] [Related]
75. Usefulness of skeletal muscle measurement by computed tomography in patients with esophageal cancer: changes in skeletal muscle mass due to neoadjuvant therapy and the effect on the prognosis.
Yamamoto M; Ozawa S; Koyanagi K; Kazuno A; Ninomiya Y; Yatabe K; Higuchi T; Kanamori K; Tajima K
Surg Today; 2023 Jun; 53(6):692-701. PubMed ID: 36763134
[TBL] [Abstract][Full Text] [Related]
76. Optimal Cutoff Values of Skeletal Muscle Index to Define Sarcopenia for Prediction of Survival in Patients with Advanced Gastric Cancer.
Nishigori T; Tsunoda S; Obama K; Hisamori S; Hashimoto K; Itatani Y; Okada K; Sakai Y
Ann Surg Oncol; 2018 Nov; 25(12):3596-3603. PubMed ID: 30167910
[TBL] [Abstract][Full Text] [Related]
77. Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer.
Mallet R; Modzelewski R; Lequesne J; Mihailescu S; Decazes P; Auvray H; Benyoucef A; Di Fiore F; Vera P; Dubray B; Thureau S
Radiat Oncol; 2020 May; 15(1):116. PubMed ID: 32443967
[TBL] [Abstract][Full Text] [Related]
78. Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer.
Griffin OM; Duggan SN; Ryan R; McDermott R; Geoghegan J; Conlon KC
Pancreatology; 2019 Sep; 19(6):850-857. PubMed ID: 31362865
[TBL] [Abstract][Full Text] [Related]
79. Skeletal muscle density is an independent predictor of diffuse large B-cell lymphoma outcomes treated with rituximab-based chemoimmunotherapy.
Chu MP; Lieffers J; Ghosh S; Belch A; Chua NS; Fontaine A; Sangha R; Turner RA; Baracos VE; Sawyer MB
J Cachexia Sarcopenia Muscle; 2017 Apr; 8(2):298-304. PubMed ID: 27897411
[TBL] [Abstract][Full Text] [Related]
80. Percentile-based averaging and skeletal muscle gauge improve body composition analysis: validation at multiple vertebral levels.
Marquardt JP; Roeland EJ; Van Seventer EE; Best TD; Horick NK; Nipp RD; Fintelmann FJ
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):190-202. PubMed ID: 34729952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
